| Leyla Azis, MD | |
|
50 Foden Rd, Ste 3, South Portland, ME 04106-1718 | |
| (207) 774-5816 | |
| (207) 523-8594 |
| Full Name | Leyla Azis |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 27 Years |
| Location | 50 Foden Rd, Ste 3, South Portland, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487871414 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 18683 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine Medical Center | Portland, ME | Hospital |
| Stephens Memorial Hospital | Norway, ME | Hospital |
| Northern Light Mercy Hospital | Portland, ME | Hospital |
| Mid Coast Hospital | Brunswick, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maine Medical Partners | 9335043967 | 789 |
| Mainehealth | 7517860588 | 2067 |
| Mercy Hospital | 6103737812 | 207 |
News Archive
An FDA scientist whose complaints about the agency's approval process for medical devices led to a controversial email monitoring program had filed lawsuits against two hospitals where he worked and also sued a dozen medical-device companies.
In a large epidemiological study, researchers found that people who drank three or more servings of fruit and vegetable juices per week had a 76 percent lower risk of developing Alzheimer's disease than those who drank juice less than once per week.
ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss. The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery.
Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs). These abnormal growths can lead to seizures, strokes, hemorrhages, and other serious conditions, yet their precise molecular cause has never been determined.
LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that five new large pharma clients have placed initial studies with the Company following the successful pre-qualification of its sites. These new clients are expected to represent at least 5-10% of the Company's revenues by 2011.
› Verified 1 days ago
| Entity Name | Mercy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629078712 PECOS PAC ID: 6103737812 Enrollment ID: O20040217000943 |
News Archive
An FDA scientist whose complaints about the agency's approval process for medical devices led to a controversial email monitoring program had filed lawsuits against two hospitals where he worked and also sued a dozen medical-device companies.
In a large epidemiological study, researchers found that people who drank three or more servings of fruit and vegetable juices per week had a 76 percent lower risk of developing Alzheimer's disease than those who drank juice less than once per week.
ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss. The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery.
Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs). These abnormal growths can lead to seizures, strokes, hemorrhages, and other serious conditions, yet their precise molecular cause has never been determined.
LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that five new large pharma clients have placed initial studies with the Company following the successful pre-qualification of its sites. These new clients are expected to represent at least 5-10% of the Company's revenues by 2011.
› Verified 1 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598780447 PECOS PAC ID: 9335043967 Enrollment ID: O20040220000847 |
News Archive
An FDA scientist whose complaints about the agency's approval process for medical devices led to a controversial email monitoring program had filed lawsuits against two hospitals where he worked and also sued a dozen medical-device companies.
In a large epidemiological study, researchers found that people who drank three or more servings of fruit and vegetable juices per week had a 76 percent lower risk of developing Alzheimer's disease than those who drank juice less than once per week.
ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss. The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery.
Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs). These abnormal growths can lead to seizures, strokes, hemorrhages, and other serious conditions, yet their precise molecular cause has never been determined.
LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that five new large pharma clients have placed initial studies with the Company following the successful pre-qualification of its sites. These new clients are expected to represent at least 5-10% of the Company's revenues by 2011.
› Verified 1 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
An FDA scientist whose complaints about the agency's approval process for medical devices led to a controversial email monitoring program had filed lawsuits against two hospitals where he worked and also sued a dozen medical-device companies.
In a large epidemiological study, researchers found that people who drank three or more servings of fruit and vegetable juices per week had a 76 percent lower risk of developing Alzheimer's disease than those who drank juice less than once per week.
ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss. The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery.
Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs). These abnormal growths can lead to seizures, strokes, hemorrhages, and other serious conditions, yet their precise molecular cause has never been determined.
LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that five new large pharma clients have placed initial studies with the Company following the successful pre-qualification of its sites. These new clients are expected to represent at least 5-10% of the Company's revenues by 2011.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leyla Azis, MD 100 Gannett Drive, Suite C, South Portland, ME 04106 Ph: (207) 523-3649 | Leyla Azis, MD 50 Foden Rd, Ste 3, South Portland, ME 04106-1718 Ph: (207) 774-5816 |
News Archive
An FDA scientist whose complaints about the agency's approval process for medical devices led to a controversial email monitoring program had filed lawsuits against two hospitals where he worked and also sued a dozen medical-device companies.
In a large epidemiological study, researchers found that people who drank three or more servings of fruit and vegetable juices per week had a 76 percent lower risk of developing Alzheimer's disease than those who drank juice less than once per week.
ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss. The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery.
Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs). These abnormal growths can lead to seizures, strokes, hemorrhages, and other serious conditions, yet their precise molecular cause has never been determined.
LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that five new large pharma clients have placed initial studies with the Company following the successful pre-qualification of its sites. These new clients are expected to represent at least 5-10% of the Company's revenues by 2011.
› Verified 1 days ago
Dr. Jonathan B Zuckerman, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Road, West Building Suite 103, South Portland, ME 04106 Phone: 207-828-1122 Fax: 207-828-0188 | |
Laureen A Biczak, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd, Ste 3, South Portland, ME 04106 Phone: 207-774-5816 Fax: 207-523-8594 | |
Pamela Egan, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 265 Western Ave Ste 2, South Portland, ME 04106 Phone: 207-661-0200 | |
Sylvia Vania Alarcon Velasco, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 265 Western Ave Ste 2, South Portland, ME 04106 Phone: 207-661-0200 | |
Dr. Christopher G Tretter, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Mainehealth Cancer Care, 265 Western Ave Suite 2, South Portland, ME 04106 Phone: 207-661-0200 | |
Dr. Emily V Wood, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd, Ste 3, South Portland, ME 04106 Phone: 207-774-5816 Fax: 207-523-8594 | |
Dr. Daniel J Diekema, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 41 Donald B Dean Dr, South Portland, ME 04106 Phone: 207-661-7901 |